Late-life onset psychotic symptoms and incident cognitive impairment in people without dementia: modification by genetic risk for Alzheimer’s disease
dc.contributor.author | Creese, B | |
dc.contributor.author | Arathimos, R | |
dc.contributor.author | Aarsland, D | |
dc.contributor.author | Ballard, C | |
dc.contributor.author | Brooker, H | |
dc.contributor.author | Hampshire, A | |
dc.contributor.author | Corbett, A | |
dc.contributor.author | Ismail, Z | |
dc.date.accessioned | 2023-04-14T15:37:55Z | |
dc.date.issued | 2023-04-30 | |
dc.date.updated | 2023-04-14T15:16:58Z | |
dc.description.abstract | INTRODUCTION: Late-life onset psychosis is associated with faster progression to dementia in cognitively normal people, but little is known about its relationship to cognitive impairment in advance of dementia. METHODS: Clinical and genetic data from 2,750 people over 50 without dementia were analyzed. Incident cognitive impairment was operationalized using the IQCODE and psychosis was rated using the Mild Behavioral Impairment Checklist (henceforth MBI-psychosis). The whole sample was analyzed before stratification on APOE-ε4 status. RESULTS: In Cox proportional hazards models, MBI-psychosis had a higher hazard for cognitive impairment relative to the No Psychosis group (hazard ratio (HR):3.6, 95% CI:2.2-11 6, p<0.0001). The hazard for MBI-psychosis was higher in APOE-ε4 carriers and there was an interaction between the two (HR for interaction: 3.4, 95% CI:1.2-9.8, p=0.02). DISCUSSION: Psychosis assessment in the MBI framework is associated with incident cognitive impairment in advance of dementia, these symptoms may be particularly important in the context of APOE genotype. | en_GB |
dc.description.sponsorship | Medical Research Council (MRC) | en_GB |
dc.description.sponsorship | National Institute for Health and Care Research (NIHR) | en_GB |
dc.description.sponsorship | Canadian Institutes of Health Research | en_GB |
dc.identifier.citation | Vol. 9 (2), article e12386 | en_GB |
dc.identifier.doi | 10.1002/trc2.12386 | |
dc.identifier.grantnumber | MC_PC_17189 | en_GB |
dc.identifier.grantnumber | BCA 2633 | en_GB |
dc.identifier.uri | http://hdl.handle.net/10871/132910 | |
dc.identifier | ORCID: 0000-0001-6490-6037 (Creese, Byron) | |
dc.language.iso | en | en_GB |
dc.publisher | Wiley / Alzheimer’s Association | en_GB |
dc.rights | © 2023 The Authors. Alzheimer’s & Dementia: Translational Research & Clinical Interventions published by Wiley Periodicals LLC on behalf of Alzheimer’s Association. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. | en_GB |
dc.subject | mild behavioral impairment | en_GB |
dc.subject | APOE | en_GB |
dc.subject | neuropsychiatric symptoms | en_GB |
dc.subject | psychosis | en_GB |
dc.subject | cognition | en_GB |
dc.title | Late-life onset psychotic symptoms and incident cognitive impairment in people without dementia: modification by genetic risk for Alzheimer’s disease | en_GB |
dc.type | Article | en_GB |
dc.date.available | 2023-04-14T15:37:55Z | |
dc.identifier.issn | 2352-8737 | |
dc.description | This is the final version. Available on open access from Wiley via the DOI in this record | en_GB |
dc.identifier.journal | Alzheimer's and Dementia: Translational Research and Clinical Interventions | en_GB |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | en_GB |
dcterms.dateAccepted | 2023-04-01 | |
dcterms.dateSubmitted | 2022-10-18 | |
rioxxterms.version | VoR | en_GB |
rioxxterms.licenseref.startdate | 2023-04-01 | |
rioxxterms.type | Journal Article/Review | en_GB |
refterms.dateFCD | 2023-04-14T15:17:00Z | |
refterms.versionFCD | AM | |
refterms.dateFOA | 2023-05-09T14:55:01Z | |
refterms.panel | A | en_GB |
Files in this item
This item appears in the following Collection(s)
Except where otherwise noted, this item's licence is described as © 2023 The Authors. Alzheimer’s & Dementia: Translational Research & Clinical Interventions published by Wiley Periodicals LLC on behalf of Alzheimer’s Association. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided
the original work is properly cited.